cyc 202 has been researched along with Cancer of Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, Y; Ding, D; Ding, L; Han, D; Huang, H; Ji, G; Jiang, W; Liu, JO; Ma, X; Pan, Y; Saiyin, H; Wu, J; Yi, Q; Yu, L; Zhang, Y; Zhu, P; Zuo, J | 1 |
| Ardelt, MA; Brandl, L; De Toni, EN; Ehrlich, SM; Gerbes, AL; Kirchner, T; Lehr, T; Liebl, J; Mayr, D; Vollmar, AM; Zahler, S | 1 |
| Gahr, S; Hahn, EG; Herold, C; Ocker, M; Peter, G; Wissniowski, TT | 1 |
| Graña, X; Knudsen, ES; Mayhew, CN; Reed, CA; Rivadeneira, DB; Sotillo, E; Thangavel, C | 1 |
| Bhat, MK; Sharma, A | 1 |
5 other study(ies) available for cyc 202 and Cancer of Liver
| Article | Year |
|---|---|
Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.
Topics: 3' Untranslated Regions; Animals; Carcinoma, Hepatocellular; Cell Cycle; Cyclin E; Cyclin-Dependent Kinase 2; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Nuclear Factor 90 Proteins; Oncogene Proteins; Purines; RNA Stability; Roscovitine | 2015 |
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Hepatocellular; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Liver Neoplasms; Mice; Mice, SCID; Purines; RNA, Neoplasm; Roscovitine; Treatment Outcome | 2015 |
The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Cell Line, Tumor; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; Liver Neoplasms; Purines; Pyridines; Roscovitine | 2008 |
Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Topics: Adenovirus E1A Proteins; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Disease Models, Animal; E2F Transcription Factors; Gene Knockdown Techniques; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Male; Mice; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; RNA Interference; Roscovitine; Time Factors; Transfection | 2010 |
Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Carboplatin; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Down-Regulation; Fluorouracil; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Purines; Quercetin; Roscovitine; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |